CNBT
TAK icon

Cornerstone National Bank & Trust’s Takeda Pharmaceutical TAK Stock Holding History

Cornerstone National Bank & Trust’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-956
Closed -$17.9K – 223
2026
Q1 		$17.9K Buy
956
+302
+46% +$5.3K 0.01% 160
2025
Q4 		$10.2K Hold
654
– – ﹤0.01% 155
2025
Q3 		$9.57K Sell
654
-220
-25% -$3.27K ﹤0.01% 144
2025
Q2 		$13.5K Sell
874
-1
-0.1% -$15 0.01% 134
2025
Q1 		$13K Buy
+875
New +$12.3K 0.01% 134

Other funds holding TAK

CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
CCA
Catalyst Capital Advisors Huntington, New York $6.03B AUM 24.5% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SCP
Sivia Capital Partners Mill Valley, California $822M AUM 48.82% 1-Year Est. Return

Cornerstone National Bank & Trust's TAK Position: Q2 2026 in Review

Cornerstone National Bank & Trust sold out of Takeda Pharmaceutical (TAK) in Q2 2026, closing a stake of 956 shares — an estimated $17.9K sold.

Cornerstone National Bank & Trust first reported a position in TAK in Q1 2025 and held it in 5 quarters. The position peaked at $17.9K in Q1 2026. 124 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Cornerstone National Bank & Trust reported no remaining Takeda Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Cornerstone National Bank & Trust sold 956 Takeda Pharmaceutical shares in Q2 2026, an estimated $17.9K.
  • Cornerstone National Bank & Trust first reported a position in Takeda Pharmaceutical in Q1 2025 and held it in 5 quarters.
  • Cornerstone National Bank & Trust's Takeda Pharmaceutical position peaked at $17.9K in Q1 2026.
  • 124 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Cornerstone National Bank & Trust's 13F filing for Q2 2026, filed 21 Jul 2026.